US FDA Imports Alert Hits Sun Pharma's Halol Manufacturing Plant After OAI Classification
Sun Pharmaceutical Industries has confirmed that its Halol manufacturing facility in Gujarat, India, has been classified as “Official Action Indicated” (OAI) by the US Food and Drug Administration following a compliance inspection conducted in June 2025.
Halol Manufacturing Facility | 11/09/2025 | By Darshana | 384
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy